Cancer Pharmacology Services
Offering a wide range of targeted oncology services and translational models. Our comprehensive platform includes:
- in vitro biochemical, biophysical, and cell-based assays, including
- 600+ human cancer cell lines
- 70+ PDX-derived cell lines
- SPR, HTRF, ELISA, and FRET techniques
- ex vivo PD analysis, including:
- histopathology services
- NGS
- Flow cytometry
- Gene/protein expression analysis
- in vivo tumor models, including:
- 320+ CDX and 1,400+ PDX models, covering 30 cancer types
- 32 drug resistant models across 11 key targets
- Transgenic mice covering 20+ targets
- 20+ PBMC/HSC humanized models
- 42 orthotopic models for 15 cancer types
- 32 metastatic models across 7 cancer types
- 88 syngeneic models covering 21 cancer types
View our extensive panel of translational oncology services
Cancer Pharmacology Services
